Literature DB >> 27988301

Leishmania and its quest for iron: An update and overview.

Amir Zaidi1, Krishn Pratap Singh1, Vahab Ali2.   

Abstract

Parasites of genus Leishmania are the causative agents of complex neglected diseases called leishmaniasis and continue to be a significant health concern globally. Iron is a vital nutritional requirement for virtually all organisms, including pathogenic trypanosomatid parasites, and plays a crucial role in many facets of cellular metabolism as a cofactor of several enzymes. Iron acquisition is essential for the survival of parasites. Yet parasites are also vulnerable to the toxicity of iron and reactive oxygen species. The aim of this review is to provide an update on the current knowledge about iron acquisition and usage by Leishmania species. We have also discussed about host strategy to modulate iron availability and the strategies deployed by Leishmania parasites to overcome iron withholding defences and thus favour parasite growth within host macrophages. Since iron plays central roles in the host's response and parasite metabolism, a comprehensive understanding of the iron metabolism is beneficial to identify potential viable therapeutic opportunities against leishmaniasis.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Iron homeostasis; Leishmania; Macrophage

Mesh:

Substances:

Year:  2016        PMID: 27988301     DOI: 10.1016/j.molbiopara.2016.12.004

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  6 in total

Review 1.  The Possible Role of Selected Vitamins and Minerals in the Therapeutic Outcomes of Leishmaniasis.

Authors:  V Udaya Kumar; Muhammed Favas Kt; Ayush Sharma; Priya Bisht; Sameer Dhingra; V Ravichandiran; M Ramesh; Krishna Murti
Journal:  Biol Trace Elem Res       Date:  2022-07-02       Impact factor: 3.738

2.  Proteomic Analysis Reveals a Predominant NFE2L2 (NRF2) Signature in Canonical Pathway and Upstream Regulator Analysis of Leishmania-Infected Macrophages.

Authors:  Juliana Perrone Bezerra de Menezes; Ricardo Khouri; Camila Victoria Sousa Oliveira; Antonio Luis de Oliveira Almeida Petersen; Tais Fontoura de Almeida; Flávia R L Mendes; Amanda do Amor Divino Rebouças; Amanda Lopes Lorentz; Nívea Farias Luz; Jonilson Berlink Lima; Pablo Ivan Pereira Ramos; Rodrigo Pedro Soares; Jeronimo Nunes Rugani; Gregory A Buck; Marco Aurélio Krieger; Fabrício Klerynton Marchini; Áislan de Carvalho Vivarini; Ulisses Gazos Lopes; Valéria de Matos Borges; Patricia Sampaio Tavares Veras
Journal:  Front Immunol       Date:  2019-06-28       Impact factor: 7.561

3.  Iron trafficking in patients with Indian Post kala-azar dermal leishmaniasis.

Authors:  Aishwarya Dighal; Debanjan Mukhopadhyay; Ritika Sengupta; Srija Moulik; Shibabrata Mukherjee; Susmita Roy; Surya Jyati Chaudhuri; Nilay K Das; Mitali Chatterjee
Journal:  PLoS Negl Trop Dis       Date:  2020-02-05

4.  Mathematical Modelling Using Predictive Biomarkers for the Outcome of Canine Leishmaniasis upon Chemotherapy.

Authors:  Rafaela de Sousa Gonçalves; Flaviane Alves de Pinho; Ricardo Jorge Dinis-Oliveira; Rui Azevedo; Joana Gaifem; Daniela Farias Larangeira; Eduardo Milton Ramos-Sanchez; Hiro Goto; Ricardo Silvestre; Stella Maria Barrouin-Melo
Journal:  Microorganisms       Date:  2020-05-15

5.  A MFS-like plasma membrane transporter required for Leishmania virulence protects the parasites from iron toxicity.

Authors:  Maria Fernanda Laranjeira-Silva; Wanpeng Wang; Tamika K Samuel; Fernando Y Maeda; Vladimir Michailowsky; Iqbal Hamza; Zhongchi Liu; Norma W Andrews
Journal:  PLoS Pathog       Date:  2018-06-15       Impact factor: 6.823

6.  Evaluation of the Pharmacophoric Role of the O-O Bond in Synthetic Antileishmanial Compounds: Comparison between 1,2-Dioxanes and Tetrahydropyrans.

Authors:  Margherita Ortalli; Stefania Varani; Giorgia Cimato; Ruben Veronesi; Arianna Quintavalla; Marco Lombardo; Magda Monari; Claudio Trombini
Journal:  J Med Chem       Date:  2020-10-22       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.